1999
Follow‐up recommendations for patients with American Joint Committee on Cancer Stages I–III malignant melanoma
Poo‐Hwu W, Ariyan S, Lamb L, Papac R, Zelterman D, Hu G, Brown J, Fischer D, Bolognia J, Buzaid A. Follow‐up recommendations for patients with American Joint Committee on Cancer Stages I–III malignant melanoma. Cancer 1999, 86: 2252-2258. PMID: 10590365, DOI: 10.1002/(sici)1097-0142(19991201)86:11<2252::aid-cncr12>3.0.co;2-q.Peer-Reviewed Original ResearchConceptsCancer stage IAmerican Joint CommitteePatient education programStage IYale Melanoma UnitSurveillance scheduleSymptomatic recurrenceMelanoma UnitSurveillance examinationsJoint CommitteeOverall survival rateStage of diseaseDetection of recurrenceAsymptomatic recurrenceAsymptomatic patientsDistant recurrenceLocoregional recurrenceHazard ratioDisease recurrenceInitial visitMore recurrencesMost recurrencesLate recurrenceMelanoma patientsRecurrence group
1997
Patterns of Care for Cancer of the Larynx in the United States
Shah J, Karnell L, Hoffman H, Ariyan S, Brown G, Fee W, Glass A, Goepfert H, Ossoff R, Fremgen A. Patterns of Care for Cancer of the Larynx in the United States. JAMA Otolaryngology - Head & Neck Surgery 1997, 123: 475-483. PMID: 9158393, DOI: 10.1001/archotol.1997.01900050021002.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsAdvanced-stage patientsRadiation therapyRegional metastasesLaryngeal cancerStage IIIDisease-specific survival outcomesFive-year survival rateStage IV diseaseAmerican Joint CommitteeEarly-stage patientsSeries of patientsSquamous cell carcinomaPatterns of careCase-mix characteristicsRadiochemotherapy protocolHospital recordsN classificationNonsurgical treatmentTreatment patternsSurvival outcomesCell carcinomaTreatment characteristicsLarge seriesPatientsUS hospitals